| Juan Andres Head Global Technical Operations Novartis Pharma AG | |
| Julie Brown Chief Financial Officer Smith & Nephew | |
| Walter Capone President Multiple Myeloma Research Foundation | |
| Glen de Vries President Medidata Solutions | |
| Sir Andrew Dillon Chief Executive National Institute for Health and Care Excellence | |
| Michael Doherty Global Head, Pharma Regulatory Affairs Hoffmann La- Roche | |
| Dr Hans-Georg Eichler Senior Medical Officer European Medicines Agency (EMA) | |
| J.P Errico Chairman, Founder, Principal Investor and CEO, electroCore | |
| Kristoffer Famm VP Bioelectronics R&D, GlaxoSmithKline | |
| The Rt Hon George Freeman Minister for Life Sciences UK | |
| Dr Julie Gerberding President, Vaccines Merck Vaccines | |
| Professor Ian Goldin Director, Oxford Martin School University of Oxford | |
| Peter Grant Chief Executive Officer Skyepharma | |
| Philipp Gutzwiller Global Head Healthcare Lloyds Banking Group | |
| Christian Hogg Executive Director and Chief Executive Officer Hutchison China MediTech Limited | |
| Heiner Hoppmann Chief Executive Officer Aenova Holding | |
| Bahija Jallal Executive Vice President, AstraZeneca Head, MedImmune | |
| Joseph Jimenez Chief Executive Officer Novartis | |
| Pranit Kumar Global Client Partner, Life Sciences Wipro | |
| Wim Leereveld Chief Executive Officer and Founder Access to Medicine Index | |
| Daniel Mahoney Fund Manager-Healthcare Polar Capital | |
| Reynold W. (Pete) Mooney Global Managing Director, Life Sciences and Health Care Deloitte Touche Tohmatsu | |
| Dominic Moorhead Global Financial Controller Takeda Pharmaceuticals | |
| Dr Flemming Ornskov Chief Executive Officer Shire | |
| Stefan Oschmann Member of the Executive Board, CEO Pharma Merck | |
| Tom Pike Chief Executive Officer Quintiles | |
| Sandeep Raju Vice President & Head of Life Sciences Europe Wipro | |
| Dr John Reed Head of Pharma Research & Early Development Hoffmann La-Roche | |
| Hanno Ronte Partner Monitor Deloitte | |
| Brent Saunders CEO and President Actavis | |
| Simon Stevens Chief Executive Officer NHS England | |
| Rob ten Hoedt Executive Vice President and President EMEA & Canada, Medtronic Chairman, Eucomed | |
| Professor Christofer Toumazou Founder and Chief Scientist, Institute of Biomedical Engineering, Imperial College Chief Executive Officer, DNA Electronics | |
| David Venter VP, Corporate, Commercial, & Supply Chain Capability Lead GlaxoSmithKline | |
| Andrew Ward Pharmaceuticals Correspondent Financial Times | |
| Peter Wilden, Ph. D. Chief Financial Officer and Executive Vice President Ferring Pharmaceuticals | |
| 17-18 November 2014 | Marriott Grosvenor | ||
